Arne Kandulski

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag et al. · Gastroenterology · 2019 · 294 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Esophageal Intraluminal Baseline Impedance Differentiates Gastroesophageal Reflux Disease From Functional Heartburn

Arne Kandulski, Jochen Weigt, Carlos Caro et al. · Clinical Gastroenterology and Hepatology · 2014 · 135 citations

Medicine, Clinical Sciences, Physiology +8

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Naturally Occurring Regulatory T cells (CD4⁺, CD25^high, FOXP3⁺) in the Antrum and Cardia are Associated with Higher <i>H. pylori</i> Colonization and Increased Gene Expression of TGF‐β1

Arne Kandulski, Thomas Wex, Doerthe Kuester et al. · Helicobacter · 2008 · 85 citations

Life Sciences, Immunology, Infectious Diseases +17